Claude Preudhomme

发表

Correction: Cost of cancer diagnosis using next-generation sequencing targeted gene panels in routine practice: a nationwide French study

Patricia Marino, Rajae Touzani, Lionel Perrier, 2018, European Journal of Human Genetics.

Clinical impact of gene mutations and lesions detected by SNP-array karyotyping in acute myeloid leukemia patients in the context of gemtuzumab ozogamicin treatment: Results of the ALFA-0701 trial

Sylvie Chevret, Claude Preudhomme, Hassan Farhat, 2014, Oncotarget.

Several types of mutations of the Abl gene can be found in chronic myeloid leukemia patients resistant to STI571, and they can pre-exist to the onset of treatment.

Claude Preudhomme, Pierre Fenaux, C. Preudhomme, 2002, Blood.

Mutations affecting mRNA splicing define distinct clinical phenotypes and correlate with patient outcome in myelodysplastic syndromes.

Claude Preudhomme, Daniel Birnbaum, Olivier Kosmider, 2012, Blood.

Cost of cancer diagnosis using next-generation sequencing targeted gene panels in routine practice: a nationwide French study

Lionel Perrier, Isabelle Durand-Zaleski, Rajae Touzani, 2018, European Journal of Human Genetics.

Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party.

Torsten Haferlach, Claude Preudhomme, Wolfgang Kern, 2018, Blood.

Serum 2-hydroxyglutarate production in IDH1- and IDH2-mutated de novo acute myeloid leukemia: a study by the Acute Leukemia French Association group.

Claude Preudhomme, Robert Barouki, Serge Koscielny, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

ASXL2 is essential for haematopoiesis and acts as a haploinsufficient tumour suppressor in leukemia

Eunhee Kim, Claude Preudhomme, Alessandro Pastore, 2017, Nature Communications.

Multi‐loci diagnosis of acute lymphoblastic leukaemia with high‐throughput sequencing and bioinformatics analysis

Claude Preudhomme, Mikaël Salson, Mathieu Giraud, 2016, British journal of haematology.

A 17-gene stemness score for rapid determination of risk in acute leukaemia

Claude Preudhomme, Peter W. Zandstra, Bob Löwenberg, 2016, Nature.

Imatinib plus peginterferon alfa-2a in chronic myeloid leukemia.

Claude Preudhomme, Philippe Rousselot, A. Vekhoff, 2010, The New England journal of medicine.

Fast multiclonal clusterization of V(D)J recombinations from high-throughput sequencing

Claude Preudhomme, Mikaël Salson, Mathieu Giraud, 2014, BMC Genomics.

Mutations in the ABL kinase domain pre-exist the onset of imatinib treatment.

Claude Preudhomme, C. Preudhomme, C. Roche-Lestienne, 2003, Seminars in hematology.